Angiopoietin-like 3 and subclinical peripheral arterial disease: Evidence from the Brisighella Heart Study

Eur J Prev Cardiol. 2020 Dec;27(19):2251-2254. doi: 10.1177/2047487319884378. Epub 2019 Oct 24.

Authors

Massimiliano Ruscica¹, Chiara Macchi¹, Federica Fogacci², Nicola Ferri³, Elisa Grandi², Elisabetta Rizzoli², Sergio D'Addato², Claudio Borghi², Arrigo Fg Cicero²; Brisighella Heart Study Group

Affiliations

¹ Pharmacological and Biomolecular Sciences Department, University of Milan, Italy.
² Medical and Surgical Sciences Department, Alma Mater Studiorum University of Bologna, Italy.
³ Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Italy.

PMID: 31648549
DOI: 10.1177/2047487319884378

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Aged
Angiopoietin-Like Protein 3
Angiopoietin-like Proteins / blood*
Ankle Brachial Index
Female
Humans
Italy / epidemiology
Longitudinal Studies
Male
Peripheral Arterial Disease
Proprotein Convertase 9 / blood*
Retrospective Studies
Risk Factors

Substances

ANGPTL3 protein, human
Angiopoietin-Like Protein 3
Angiopoietin-like Proteins
PCSK9 protein, human
Proprotein Convertase 9